Involvement of spinal cholecystokininB receptors in mediating neurotensin hyperalgesia from the medullary nucleus raphe magnus in the rat

Journal of Pharmacology and Experimental Therapeutics

Volumn 278, Issue 1, 1996, Pages 90-96

  Urban, M O ^a   Smith, D J ^b   Gebhart, G F ^b  

^a UNIVERSITY OF IOWA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA; BENZODIAZEPINE DERIVATIVE; CARBANILAMIDE DERIVATIVE; CHOLECYSTOKININ OCTAPEPTIDE; CHOLECYSTOKININ RECEPTOR; DEVAZEPIDE; HORMONE ANTAGONIST; NEUROTENSIN; CHOLECYSTOKININ A RECEPTOR ANTAGONIST; CHOLECYSTOKININ B RECEPTOR; CHOLECYSTOKININ B RECEPTOR ANTAGONIST; NARCOTIC ANALGESIC AGENT; PROGLUMIDE;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; DRUG EFFECT; HYPERALGESIA; MALE; MEDULLA OBLONGATA; RAT; SPINAL CORD; SPRAGUE DAWLEY RAT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; AREA UNDER THE CURVE; CONTROLLED STUDY; ETIOLOGY; INTRATHECAL DRUG ADMINISTRATION; MICROINJECTION; NERVE PROJECTION; NONHUMAN; PRIORITY JOURNAL; RAPHE MAGNUS NUCLEUS; TAIL FLICK TEST;

ANIMALS; BENZODIAZEPINONES; DEVAZEPIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; HORMONE ANTAGONISTS; HYPERALGESIA; MALE; MEDULLA OBLONGATA; NEUROTENSIN; PHENYLUREA COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CHOLECYSTOKININ; SINCALIDE; SPINAL CORD;

EID: 0030302491     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. BABER, N. S., DOURISH, C. T. AND HILL, D. R.: The role of CCK, caerulein, and CCK antagonists in nociception. Pain 39: 307-328, 1989.
2. BARBAZ, B. S., AUTRY, W. L., AMBROSE, F. G., HALL, N. R. AND LIEBMAN, J. M.: Antinociceptive profile of sulfated CCK-8: Comparison with CCK-4, unsulfated CCK-8 and other neuropeptides. Neuropharmacology 25: 823-829, 1986.
3. BEHBEHANI, M. M.: Physiological mechanisms of the analgesic effect of neurotensin. Ann. N. Y. Acad. Sci. 668: 253-265, 1992.
4. BEHBEHANI, M. M. AND PERT, A.: A mechanism for the analgesic effect of neurotensin as revealed by behavioral and electrophysiological techniques. Brain Res. 324: 35-42, 1984.
5. CLINESCHMIDT, B. V., McGUFFIN, J. C. AND BUNTING P. B.: Neurotensin: Antinociceptive action in rodents. Eur. J. Pharmacol. 54: 129-139, 1979.
6. D'AMOUR, F. E. AND SMITH, D. L.: A method for determining loss of pain sensation. J. Pharmacol, Exp. Ther. 72: 74-79, 1941.
7. DOURISH, C. T. AND HILL, D. R.: Classification and function of CCK receptors. Trends Pharmacol. Sci. 8: 207-208, 1987.
8. DOURISH, C. T., O'NEILL, M. F., COUGLAN, J., KITCHENER, S. J., HAWLEY, D. AND IVERSON, S. D.: The selective CCKB antagonist L-365260 enhances morphine analgesia and prevents morphine tolerance in the rat. Eur. J. Pharmacol. 175: 35-44, 1990.
9. FANG, F. G., MOREAU, J. L. AND FIELDS, H. L.: Dose dependent antinociceptive action of neurotensin microinjected into the rostroventromedial medulla of the rat. Brain Res. 420: 171-174, 1987.
10. FARIS, P. L., KOMISARUK, B. R., WATKINS, L. R. AND MAYER, D. J.: Evidence for the neuropeptide cholecystokinin as an antagonist of opiate analgesia. Science 219: 310-312, 1983.
11. FIELDS, H. L., HEINRICHER, M. M. AND MASON, P.: Neurotransmitters in nociceptive modulatory circuits. Annu. Rev. Neurosci. 7: 309-338, 1991.
12. HILL, R. G., HUGHES, J. AND PITTAWAY, K. M.: Antinociceptive action of cholecystokinin octapeptide (CCK-8) and related peptides in rats and mice: Effects of naloxone and peptidase inhibitors. Neuropharmacology 26: 289-300, 1987.
13. HILL, D. R. AND WOODRUFF, G. N.: Differentiation of central cholecystokinin receptor binding sites using the non-peptide antagonists MK-329 and L-365260. Brain Res. 526: 276-283, 1990.
14. HONG, E. K. AND TAKEMORI, A. E.: Indirect involvement of delta opioid receptors in cholecystokinin octapeptide-induced analgesia in mice. J. Pharmacol. Exp. Ther. 251: 594-598, 1989.
15. JURNA, I. AND ZETLER, G.: Antinociceptive effect of centrally administered caerulein and cholecystokinin octapeptide (CCK-8). Eur. J. Pharmacol. 73: 323-331, 1981.
16. KALIVAS, P. W., JENNES, L., NEMEROFF, C. B. AND PRANGE, A. J.: Neurotensin: Topographical distribution of brain sites involved in hypothermia and antinociception. J. Comp. Neurol. 210: 225-238, 1982.
17. KELLSTEIN, D. E., PRICE, D. D. AND MAYER, D. J.: Cholecystokinin and its antagonist lorglumide respectively attenuate and facilitate morphineinduced inhibition of C-fiber evoked discharges of dorsal horn nociceptive neurons. Brain Res. 540: 302-306, 1991.
18. LOTTI, V. J. AND CHANG, R. S. L.: A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365260. Eur J. Pharmacol. 162: 273-280, 1989.
19. LOTTI, V. J., PENDLETON, R. G., GOULD, R. J., HANSON, H. M., CHANG, R. S. L. AND CLINESCHMIDT, B. V.: In vivo pharmacology of L-364718, a new potent non-peptide peripheral cholecystokinin antagonist. J. Pharmacol. Exp. Ther. 241: 103-109, 1987.
20. MACIEWICZ, M., PHILIPPS, B. S., GRENIER, Y. AND POLETTI, C. E.: Edinger-Westphal nucleus: Cholecystokinin immunocytochemistry and projections to spinal cord and trigeminal nucleus of the cat. Brain Res. 299: 139-145, 1984.
21. MAIER, S. F., WIERTELAK, E. P. AND WATKINS, L. R.: Endogenous pain facilitory systems-antianalgesia and hyperalgesia. APS J. 1: 191-198, 1992.
22. MANTYH, P. W. AND HUNT, S. P.: Evidence for cholecystokinin-like immunoreactive neurons in the rat medulla oblongata which project to the spinal cord. Brain Res. 291: 49-54, 1984.
23. MARLEY, P. D., NAGY, J. I., EMSON, P. C. AND REHFELD, J. F.: Cholecystokinin in the rat spinal cord: Distribution and lack of effect of neonatal capsaicin treatment and rhizotomy. Brain Res. 238: 494-498, 1982.
24. MORAN, T. H. AND MCHUGH, P. R.: Anatomical and pharmacological differentiation of pyloric, vagal and brainstem cholecystokinin receptors. In Cholecystokinin Antagonists, ed. by R. Y. Wang and R. Schoenfeld, pp. 117-132, Alan R. Liss, New York, 1988.
25. MORAN, T. H., ROBINSON, P. H., GOLDRICH, M. S. AND MCHUGH, P. R.: Two brain cholecystokinin receptors: Implication for behavioral actions. Brain Res. 362: 175-179, 1986.
26. PAXINOS, G. AND WATSON, C.: The Rat Brain in Stereotaxic Coordinates, 2nd ed., Academic Press, New York, 1986.
27. PITTAWAY, K. M., RODRIGUEZ, R. E., HUGHES, J. AND HILL, R. G.: CCK-8 analgesia and hyperalgesia after intrathecal administration in the rat: Comparison with CCK-related peptides. Neuropeptides 10: 87-108, 1987.
28. SAKAMOTO, C., WILLIAMS, J. A. AND GOLDFINE, I. D.: Brain CCK receptors are structurally distinct from pancreas CCK receptors. Biochem. Biophys. Res. Commun. 124: 497-502, 1984.
29. SCHULTZBERG, M., DOCKRAY, G. J. AND WILLIAMS, R. G.: Capsaicin depletes CCK-like immunoreactivity detected by immunohistochemistry but not that measured by radioimmunoassay in rat dorsal spinal cord. Brain Res. 235: 205-211, 1982.
30. SKIRBOLL, L., HOKFELT, T., DOKRAY, G., REHFELD, J. F., BROWNSTEIN, M. AND CUELLO, A. C.: Evidence of periaqueductal cholecystokinin-substance P neurons projecting to the spinal cord. Neuroscience 3: 1151-1158, 1983.
31. SUH, H. H., COLLINS, K. A. AND TSENG, T.: Intrathecal cholecystokinin octapeptide attenuates the antinociception and release of immunoreactive metenkephalin induced by intraventricular 66 - endorphin in the rat. Neuropeptides 21: 131-137, 1992.
32. SUH, H. H. AND TSENG, L. F.: Differential effects of sulfated cholecystokinin octapeptide and proglumide injected intrathecally on antinociception induced by β-endorphin and morphine administered intracerebroventricularly in mice. Eur. J. Pharmacol. 179: 329-339, 1990.
33. TSENG, L. F. AND COLLINS, K. A.: Cholecystokinin administered intrathecally selectively antagonizes intracerebroventricular β-endorphin-induced tailflick inhibition in the mouse. J. Pharmacol. Exp. Ther. 260: 1086-1092, 1992.
34. URBAN, M. O. AND GEBHART, G. F.: Dose-dependent inhibition and facilitation of spinal unit responses to noxious heat by neurotensin in the nucleus raphe magnus. Abst. Soc. Neurosci. 20: 756, 1994.
35. URBAN, M. O. AND SMITH, D. J.: Role of neurotensin in the nucleus raphe magnus in opioid induced antinociception from the periaqueductal gray. J. Pharmacol. Exp. Ther. 265: 580-586, 1993.
36. URBAN, M. O. AND SMITH, D. J.: Localization of the antinociceptive and antianalgesic effects of neurotensin within the rostral ventromedial medulla. Neurosci. Lett. 174: 21-25, 1994.
37. VALVERDE, O., MALDONADO, R., FOURNIE-ZALUSKI, M. C. AND ROQUES, B. P.: Cholecystokinin B antagonists strongly potentiate antinociception mediated by endogenous enkephalins. J. Pharmacol. Exp. Ther. 270: 77-88, 1994.
38. VERGE, V. M. K, WIESENFELD-HALLIN, Z. AND HOKFELT, T.: Cholecystokinin in mammalian primary sensory neurons and spinal cord: In situ hybridization studies in rat and monkey. Eur. J. Neurosci. 5: 240-250, 1993.
39. WATKINS, L. R., KINSCHECK, I. B. AND MAYER, D. J.: Potentiation of morphine analgesia by the cholecystokinin antagonist proglumide. Brain Res. 327: 169-180, 1985a.
40. WATKINS, L. R., KINSCHECK, I. B., KAUFMAN, E. F. S., MILLER, J., FRENK, H. AND MAYER, D. J.: Cholecystokinin antagonists selectively potentiate analgesia induced by endogenous opiates. Brain Res. 327: 181-190, 1985b.
41. WIESENFELD-HALLIN, Z. AND DURANTI, R.: Intrathecal cholecystokinin interacts with morphine but not substance P in modulating the nociceptive flexor reflex in the rat. Peptides 8: 152-158, 1987.
42. WIESENFELD-HALLIN, Z., Xu, X.-J., HUGHES, J., HORWELL, D. C. AND HOKFELT, T.: PD-134,308, a selective antagonist of cholecystokinin type B receptor, enhances the analgesic effect of morphine and synergistically interacts with intrathecal galanin to depress spinal nociceptive reflexes. Proc. Natl. Acad. Sci. U.S.A. 87: 7105-7109, 1990.
43. YAKSH, T. L. AND RUDY, T. A.: Chronic catheterization of the spinal subarachnoid space. Physiol. Behav. 17: 1031-1036, 1976.
44. ZHUO, M. AND GEBHART, G. F.: Characterization of descending inhibition and facilitation from the nuclei reticularis gigantocellularis and gigantocellularis pars alpha in the rat. Pain 42: 337-350, 1990a.
45. ZHUO, M. AND GEBHART, G. F.: Spinal cholinergic and monoaminergic receptors mediate descending inhibition from the nuclei reticularis gigantocellularis (NGC) and gigantocellularis pars alpha (NGCα) in the rat. Brain Res. 635: 67-78, 1990b.
46. ZHUO, M. AND GEBHART, G. F.: Spinal serotonin receptors mediate descending facilitation of a nociceptive reflex from the nuclei reticularis gigantocellularis and gigantocellularis pars alpha in the rat. Brain Res. 550: 35-48, 1991.
47. ZHUO, M. AND GEBHART, G. F.: Characterization of descending facilitation and inhibition of spinal nociceptive transmission from the nuclei reticularis gigantocellularis and gigantocellularis pars alpha in the rat. J. Neurophysiol. 67: 1599-1614, 1992.
48. B receptor antagonist L-365260 in rat spinal cord. Eur. J. Pharmacol. 234: 147-154, 1993.